Royal Bank of Canada’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Buy
94,838
+36,517
+63% +$623K ﹤0.01% 3355
2025
Q4
$849K Sell
58,321
-1,129,977
-95% -$19.7M ﹤0.01% 3772
2025
Q3
$21.3M Buy
1,188,298
+1,127,000
+1,839% +$16.5M ﹤0.01% 1593
2025
Q2
$1.05M Buy
61,298
+22,258
+57% +$223K ﹤0.01% 3858
2025
Q1
$283K Sell
39,040
-35,730
-48% -$407K ﹤0.01% 4441
2024
Q4
$1.05M Buy
74,770
+51,424
+220% +$760K ﹤0.01% 3503
2024
Q3
$277K Sell
23,346
-24,154
-51% -$250K ﹤0.01% 4565
2024
Q2
$441K Buy
47,500
+46,937
+8,337% +$240K ﹤0.01% 4120
2024
Q1
$2K Buy
+563
New +$1.95K ﹤0.01% 6656

Other funds holding CORZ

Royal Bank of Canada's CORZ Position: Q1 2026 in Review

Royal Bank of Canada increased its Core Scientific (CORZ) stake by 63% in Q1 2026, buying an estimated $623K and bringing the position to 94,838 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3355.

Royal Bank of Canada first reported a position in CORZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $21.3M in Q3 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Royal Bank of Canada held 94,838 shares of Core Scientific worth $1.42M as of Q1 2026.
  • Royal Bank of Canada bought 36,517 Core Scientific shares in Q1 2026, an estimated $623K.
  • Core Scientific made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3355 holding.
  • Royal Bank of Canada first reported a position in Core Scientific in Q1 2024 and has held it in 9 quarters since.
  • Royal Bank of Canada's Core Scientific position peaked at $21.3M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.